Customer Complaints, Products, and Business Lines

The last section of this chapter works like a capstone because it combines customer harm with firm expansion decisions. Series 26 expects the principal to know how written complaints are retained and escalated, how arbitration-related records fit into that system, how new products are vetted before sale, and how new business lines can create additional supervisory, capital, or membership consequences. The exam is testing whether the candidate can connect a local problem to a firm-level control obligation.

That is why a complaint question is rarely only about the complaint itself. A written complaint may reveal a suitability weakness, a disclosure failure, a training gap, or a product-control issue. In the same way, a new product proposal is not just a business opportunity. It can require due diligence, revised procedures, added training, different approvals, and possibly regulatory review before launch. The principal who moves too fast is usually the one who gets the question wrong.

Events that should slow the firm down

Series 26 typically rewards the answer that pauses, documents, and escalates before the firm expands further. Growth is not the goal on the exam. Controlled growth is.

Product and business-line escalation workflow

    flowchart TD
	    A["New product, new business line, or complaint pattern appears"] --> B{"Is there current customer-harm or sales-practice risk?"}
	    B -- "Yes" --> C["Escalate immediately, preserve records, and review the affected activity"]
	    B -- "No" --> D["Begin due diligence and supervisory-impact review"]
	    C --> E{"Does the issue point to a broader product or process weakness?"}
	    D --> F{"Does the proposal fit current registrations, procedures, and controls?"}
	    E -- "Yes" --> G["Expand the review to product, training, disclosure, and procedure controls"]
	    E -- "No" --> H["Resolve the specific complaint with retained documentation"]
	    F -- "No" --> I["Pause launch or expansion until controls, approvals, and regulatory implications are addressed"]
	    F -- "Yes" --> J["Finalize training, supervision, and documentation before rollout"]
	    G --> I
	    H --> K["Monitor for recurrence or pattern risk"]
	    I --> K
	    J --> K

This is the core exam instinct: if a complaint or proposed product change exposes weak controls, the principal should widen the review before widening the business.

What Series 26 usually rewards

• A written complaint should trigger documented handling, not a quiet business-resolution shortcut.
• New-product oversight is a due-diligence and supervision problem before it is a sales opportunity.
• Repeated complaints often matter more than the emotion of any single complaint because they point to pattern risk.
• If a business-line change may affect capital, membership, or overall firm obligations, the safer answer is the one that escalates the decision beyond the immediate sales desk.

Sample exam question

A firm wants to begin selling a new packaged product that several representatives believe will be popular with current customers. At the same time, the firm has received multiple recent written complaints about unclear product-cost disclosures in a similar product line. What is the best supervisory response?

1. Launch the new product quickly because the complaints involve a different product.
2. Allow the launch but remind representatives to explain fees more carefully.
3. Pause the rollout, review whether the existing complaint pattern reveals a broader disclosure or supervision weakness, and complete due diligence and control updates before approving sales.
4. Approve the product if each representative signs an acknowledgment that they understand the prospectus.

Correct answer: 3.

Series 26 is testing whether the principal can connect customer complaints to product-control risk. A firm should not expand a product line while ignoring evidence that its current disclosure or supervision process may already be weak.